［1］LI LJ，CHAI Y，GUO XJ，et al.Effects of endoplasmic reticulum stress on autophagy and apoptosis of human leukemia cells via inhibition of the PI3K /Akt /mTOR signaling pathway［J］.Mol Med Rep，2018，17(6)：7886-7892.
［2］ZHOU J，PEI YF，CHEN G，et al.SPC24 regulates breast cancer progression by PI3K/Akt signaling［J］.Gene，2018，675:272-277.
［3］FAES S，DORMOND O.PI3K and Akt：Unfaithful partners in cancer［J］.Int J Mol Sci，2015，16(9)：21138-21152.
［4］WU XL，WANG LK，YANG DD，et al.Effects of Glut1 gene silencing on proliferation，differentiation，and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-Akt-mTOR signaling pathway［J］.J Cell Biochem，2018，119(2)：2356-2367.
［5］AO R，GUAN L，WANG Y，et al.Silencing of COL1A2，COL6A3，and THBS2 inhibits gastric cancer cell proliferation，migration，and invasion while promoting apoptosis through the PI3k-Akt signaling pathway［J］.J Cell Biochem，2018，119(6)：4420-4434.
［6］LI Z，DONG H，LI M，et al.Honokiol induces autophagy and apoptosis of osteosarcoma through PI3K/Akt/mTOR signaling pathway［J］.Mol Med Rep，2018，17(2)：2719-2723.
［7］严匡华，陈龙，严风梦.下调miR-21抑制PI3K/Akt信号通路对白血病细胞增殖凋亡的影响［J］.中国免疫学杂志，2018，34(3)：441-445.
YAN KH，CHEN L，YAN FM.Effect of down-regulation of miR-21 on proliferation and apoptosis of leukemic cells by inhibiting PI3K/Akt signaling pathway［J］.Chin J Immunol，2018，34(3)：441-445.
［8］SHIWARSKI DJ，DARR M，TELMER CA，et al.PI3K class IIα regulates δ-opioid receptor export from the trans-Golgi network［J］.Mol Biol Cell，2017，28(16)：2202-2219.
［9］MAYER IA，ARTEAGA CL.The PI3K/Akt pathway as a target for cancer treatment［J］.Annu Rev Med，2016，67：11-28.
［10］TIAN L，ZHAO Z，XIE L，et al.MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway［J］.Oncotarget，2017，9(4)：4886-4896.
［11］SAXTON RA，SABATINI DM.mTOR signaling in growth，metabolism，and disease［J］.Cell，2017，168(6)：960-976.
［12］LIEN EC，DIBBLE CC，TOKER A.PI3K signaling in cancer：Beyond Akt［J］.Curr Opin Cell Biol，2017，45：62-71.
［13］MAYER IA，ARTEAGA CL.The PI3K/Akt pathway as a target for cancer treatment［J］.Annu Rev Med，2016，67：11-28.
［14］JANAKI RM，VAISHNAVE S.BMI1 and PTEN are key determinants of breast cancer therapy：A plausible therapeutic target in breast cancer［J］.Gene，2018，15(678)：302-311.
［15］BROWN JS，BANERJI U.Maximising the potential of Akt inhibitors as anti cancer treatments［J］.Pharmacol Ther，2017，172：101-115.
［16］LIN Q，LING YB，CHEN JW，et al.Circular RNA circCDK13 suppresses cell proliferation，migration and invasion by modulating the JAK/STAT and PI3K/Akt pathways in liver cancer［J］.Int J Oncol，2018，53(1)：246-256.
［17］CAO B，LIU C，YANG G.Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway［J］.Biomed Pharmacother，2018，107：185-193.
［18］WANG S，LEI Y，CAI Z，et al.Girdin regulates the proliferation and apoptosis of pancreatic cancer cells via the PI3K/Akt signalling pathway［J］.Oncol Rep，2018，40(2)：599-608.
［19］YAO H，SU S，XIA D，et al.F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/Akt signaling pathway［J］.Biomed Pharmacother，2018，107：1712-1719.
［20］张劲远，张银旭，张俊华.PI3K/Akt信号通路对人大肠癌HCT-8/FU耐药细胞P-GP表达和耐药性的影响［J］.东南大学学报院：医学版，2013，32(2)：169-172.
ZHANG JY，ZHANG YX，ZHANG JH.Effect of PI3K/Akt signaling pathway on P-GP expression and drug resistance of HCT-8/FU resistant human colorectal cancer cells［J］.Journal of Southeast University：Medical Edition，2013，32(2)：169-172.
［21］YANG J，ZOU Y，JIANG D.Honokiol suppresses proliferation and induces apoptosis via regulation of the miR21/ PTEN/PI3K/Akt signaling pathway in human osteosarcoma cells［J］.Int J Mol Med，2018，41(4)：1845-1854.
［22］KUMAR D，HALDAR S，GORAIN M，et al.Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway［J］.BMC Cancer，2018，18(1)：52-69.
［23］MAJEWSKA E，SZELIGA M.Akt/GSK3β signaling in glioblastoma［J］.Neurochem Res，2017，42(3)：918-924.
［24］PARAMASIVM A，SAMBANTHAM S，SHABNAM J，et al.Anticancer effects of thymoquinone in mouse neuroblastoma(Neuro-2a) cells through caspase-3 activation with down-regulation of XIAP［J］.Toxicol Lett，2012，213(2)：151-159.
［25］YANG J，QIN G，LUO M,et al.RA，reciprocal positive regulationg between Cx26 and PI3K/Akt pathwang confers acquired gefitinib resistance in NSCLC cells via GJIC-in dependent in duction of EMT［J］.Cell Death Dis，2015，236(6)：e1829.
［26］SAXTON RA，SABATINI DM.mTOR signaling in growth，metabolism，and disease［J］.Cell，2017，168(6)：960-976.
［27］CHANG CZ，WU SC，CHANG CM，et al.Arctigenin，a potent ingredient of Arctium lappa L，induces endothelial nitric oxide synthase and attenuates subarachnoid hemor rhage-induced vasospasm through PI3K/Akt pathway in a rat model［J］.Biomed Res Int，2015(3)：1-10.
［28］PORTA C，PAGLINO C，MOSCA A.Targeting PI3K/Akt/mTOR signaling in cancer［J］.Frontiers inoncology，2014，4：64.
［29］ZHOU Y，LI S，LI J，et al.Effect of microRNA-135a on cell proliferation，migration，invasion，apoptosis and tumor angiogenesis through the IGF-1/PI3K/Akt signaling pathway in non-small cell lung cancer［J］.Cell Physiol Biochem，2017，42(4)：1431-1446.
［30］CHENG TC，DIN ZH，SU JH，et al.Sinulariolide suppresses cell migration and invasion by inhibiting matrix metalloproteinase-2/-9 and urokinase through the PI3K/Akt signaling pathway in human bladder cancer cells［J］.Mar Drugs，2017，15(8)：238.
［31］史善伟，许宝山.mTORC1/2 信号通路在肿瘤治疗中的应用［J］.中华口腔医学研究杂志(电子版)，2018，12(6)：383-388.
SHI SW，XU BS.Application of mTORC1/2 signal pathway in tumor therapy［J］.Chinese Journal of Stomatology Research(Electronic Edition)，2018，12(6)：383-388.
［32］OH S，KIM H，NAM K，et al.Silencing of glut1 induces chemoresistance via modulation of Akt/GSK-3β/β-catenin/survivin signaling pathway in breast cancer cells［J］.Arch Biochem Biophys，2017，636：110-122.
［33］SUN Q，CHEN X，MA J，et al.Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth［J］.Proc Natl Acad Sci USA，2011，108(10)：4129-4134.
［34］MARTINI M，CIRAOLO E，GULLUNI F，et al.Targeting PI3K in cancer：Any good news［J］.Front Oncol，2013，3：108.
［35］孙媛媛，张明智.PI3K/Akt/mTOR信号通路在Burkitt淋巴瘤中的研究进展［J］.肿瘤防治研究，2019，46(2)：169-173.
SUN YY，ZHANG MZ.Research progress of PI3K/Akt/mTOR signaling pathway in Burkitt lymphoma［J］.Cancer Prevention，2019，46(2)：169-173.
［36］张文娟，李丽娟.PI3K抑制剂在淋巴瘤中的研究进展［J］.医学综述，2019，25(8)：1517-1529.
ZHANG WJ，LI LJ.Research progress of PI3K inhibitors in lymphoma［J］.Medical Review，2019，25(8)：1517-1529.
［37］REAGAN-SHAW S，AHMAD N.RNA interference-mediateddepletion of PI3K actives forkheadbox class o transcription factors and induces cell cycle arrest and apoptosis in breast carcinoma cells［J］.Cancer Res，2006，66(2)：1062-1069,2206.
［38］JURIC D，DEBONO JS，LORUSSOP M，et al.A first in human，phasel，dose-escalation study of TAK-117，a selective PI3K α isoform inhibitor，in patients with advanceed solid malignancies［J］.Clin Cancer Res，2017，23(17)：5015-5023.
［39］董超，陈印.PI3K抑制剂在肺癌治疗中的研究进展［J］.重庆医学，2019，48(16)：2834-2837.
DONG C，CHEN Y.Research progress of PI3K inhibitors in the treatment of lung cancer［J］.Chongqing Medical Journal，2019，48(16):2834-2837.
［40］LIANG X，DENG M，ZHANG C，et al.Combined class I histone deacetylase and mTORC1/C2 inhibition suppresses the initiation and recurrence of oral squamous cell carcinomas by repressing SOX2［J］.Cancer Lett，2019，454：108-119.
［41］SHI F，ZHANG J，LIU H，et al.The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo［J］.Oncotarget，2018，9(1)：706-717.